Cardiac manifestations in HIV-infected individual;Kardiale manifestationen der HIV-infektion

Medizinische Klinik

Volumn 97, Issue 11, 2002, Pages 659-665

  Neumann, Till ^a   Ross, Birgit ^b   Hengge, Ulrich R ^c   Gerken, Guido ^b   Erbel, Raimund ^a  

^a Klinik fur Kardiologie   (Germany)

^b Abteilung fur Gastroenterologie   (Germany)

^c Abteilung für Dermatologie   (Germany)

Author keywords

AIDS; Heart; Heart failure; HIV

Indexed keywords

BACTERIAL ENDOCARDITIS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; MYOCARDITIS; PERICARDIAL EFFUSION; REVIEW;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOPSY; CARDIOMYOPATHIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ENDOCARDITIS; ENDOCARDITIS, BACTERIAL; FEMALE; HEART DISEASES; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDITIS; PERICARDIAL EFFUSION; RISK FACTORS; TIME FACTORS;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS;

EID: 18744391633     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-002-1209-x     Document Type: Review

References (66)

1. Acierno LJ. Cardiac complications in acquired immunodeficiency syndrome (AIDS): A review. J Am Coll Cardiol 1989;13:1144-54.
2. Autran B, Gorin I, Leibowitch M, Laroche L, Escande JP, Marche C. AIDS in a Haitian woman with cardiac Kaposi's sarcoma and Whipple's disease. Lancet 1983;1:767-8.
3. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-9.
4. Barbaro G, Di Lorenzo G, Grisorio B, Barbanni G. Cardiac involvement in the acquired immunodeficiency syndrome: A multicenter clinical-pathological study. AIDS Res 1998;14:1071-7.
5. Baroldi G, Corallo S, Moroni M, Repossini A, Mutinelli MR, Lazzarin A, Antonacci CM, Christina S, Negri C. Focal lymphocytic myocarditis in acquired immunodeficiency syndrome: A correlative morphologic and clinical study in 26 consecutive fatal cases. J Am Coll Cardiol 1988;12:463-9.
6. Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, Levison M, Chambers HF, Dajani AS, Gewitz MH, Newburger JW, Gerber MA, Shulman ST, Pallasch TJ, Gage TW, Ferrieri P. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; Dez 98:2936-48.
7. Bernard SA. Cardiac manifestations. In: Libman H, Witzburg RA, eds. HIV Infection: A Primary Care Manual. Boston: Little Brown, 1996:123-37.
8. Bestetti RB, Figueiredo JF, Da Costa JC. Salmonella tricuspid endocarditis in an intravenous drug abuser with human immunodeficiency virus infection. Int J Cardiol 1991;30:361-2.
9. Blanchard DG, Hagenhoff C, Chow LC, McCann HA, Dittrich HC. Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV)-infected individuals: A serial echocardiographic study. J Am Coll Cardiol 1991;17:1270-6.
10. Brivet P, Livartowski J, Herve P, Rain B, Dormont J. Pericardial cryptococcal disease in acquired immunodeficiency syndrome. Am J Med 1987;82:1273.
11. Cammarosano C, Lewis W. Cardiac lesions in acquired immunodeficiency syndrome (AIDS). J Am Coll Cardiol 1985;5:703-6.
12. Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human immunodeficiency virus-associated pericardial effusion: Report of 40 cases and review of literature. Am Heart J 1999;137:516-21.
13. Currie PF, Boon NA. Cardiac involvement in human immunodeficiency virus infection. Q J Med 1993;86:751-3.
14. Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA. Heart muscle disease related to HIV-infection: Prognostic implications. Br Med J 1994;309:1605-7.
15. Currie PF, Sutherland GR, Jacob AJ, Bell JE, Brettle RP, Boon NA. A review of endocarditis in acquired immunodeficiency syndrome and human immunodeficiency virus infection. Eur Heart J 1995;16:15-8.
16. DeCastro S, Migliau G, Silvestri A, D'Amati G, Giannantoni P, Cartoni D, Kol A, Vullo V, Cirelli A. Heart involvement in AIDS: A prospective study during various stages of the disease. Eur Heart J 1992;13:1452-9.
17. Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998;280:1497-503.
18. Detels R, Tarwater P, Phair JP, Margolick J, Riddler SA, Munoz A, Multicenter AIDS Cohort Study. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS 2001;15:347-55.
19. Deyton LR, Walker RE, Kovacs JA, Herpin B, Parker M, Masur H, Fauci AS, Lane HC. Reversible cardiac dysfunction associated with interferon alpha therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med 1989;321:1246-9.
20. Duong M, Buisson M, Cottin Y, Piroth L, Lhuiller I, Grappin M, Chavanet P, Wolff JE, Pottier H. Coronary heart disease associated with the use of human immunodeficiency virus (HIV-1 protease inhibitors: Report of four cases and review. Clin Cardiol 2001;24:690-4.
21. Eisenberg MJ, Gordon AS, Schiller NB. HIV associated pericardial effusion. Chest 1992;102:956-8.
22. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84.
23. Fink L, Reicheck N, Sutton MG. Cardiac abnormalities in acquired immune deficiency syndrome. Am J Cardiol 1984;54:1161-3.
24. Finkel TH, Banda NK. Indirect mechanisms of HIV pathogenesis. How does HIV kill T cells? Curr Opin Immunol 1994;6:605-15.
25. Fisher SD, Lipshultz SE. Cardiovascular abnormalities in HIV-infected individuals. In: Braunwald E, ed. Heart Disease: A Text Book of Cardiovascular Medicine. Philadelphia: Saunders, 2001:2211-21.
26. Francis CK. Cardiac involvement in AIDS. Curr Probl Cardiol 1990;15:569-639.
27. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol 1990;66:203-6.
28. Hastillo A, Willis HE, Hess ML. The heart as a target organ of immune injury. Curr Probl Cardiol 1991;16:377-442.
29. Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H, Schiller NB, Cheitlin MD. Pericardial effusion in AIDS: Incidence and survival. Circulation 1995;92:3229-34.
30. Hengge UR, Esser S, Rudel HP, Goos M. Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin. Eur J Cancer 2001;37:878-83.
31. Hengge UR, Ruzicka T, Tyring S, Stuschke M, Roggendorf M, Schwartz RA, Seeber S. Update on Kaposi's sarcoma and other HHV-8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations and therapy. Lancet Infect Dis 2002;2:281-92.
32. Hengge UR, Ruzicka T, Tyring S, Stuschke M, Roggendorf M, Schwartz RA, Seeber S. Update on Kaposi's sarcoma and other HHV-8 associated diseases. Part 2: Pathogenesis, Castleman's disease and pleural effusion lymphoma. Lancet Infect Dis 2002;2:352-60.
33. Henochowicz S, Mustafa M, Lawrinson WE, Pistole M, Linsay J Jr. Cardiac aspergillosis in acquired immunodeficiency syndrome. Am J Cardiol 1985;55:1239-49.
34. Herzkowitz A, Willoughby SB, Baughman KL, Schulman SP, Bardett JD. Cardiomyopathy associated with antiretroviral therapy in patients with HIV infections: A report of six cases. Ann Intern Med 1992;116:311-3.
35. Herskowitz A, Willoughby SB, Vlahov D, Baughman KL, Ansari AA. Dilated heart muscle disease associated with HIV infection. Eur Heart J 1995;16:50-5.
36. Ho DD, Pomerantz RJ, Kaplan JC. Pathogenesis of interferon with human immunodeficiency virus. N Engl J Med 1987;317:278-86.
37. Jacob AJ, Sutherland G, Bird AG, Brettle RP, Ludlam CA, McMillan A, Boon NA. Myocardial dysfunction in patients infected with HIV: Prevalence and risk factors. Br Heart J 1992;68:549-53.
38. Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestation of acquired immunodeficiency syndrome: A 1991 update. Am Heart J 1991;122:535-44.
39. Kavanaugh-McHugh AL, Ruff A, Perlman E, Hutton N, Modlin J, Rowe S. Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1991;15:347-9.
40. Kestelyn P, Lepage P, Van de Perre P. Perivasculitis of retinal vessels as an important sign in children with AIDS-related complex. Am J Ophthalmol 1985;100:614-5.
41. Koppel K, Bratt G, Eriksson M, Sandstorm E. Serum lipid levels associated with increased risk of cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection. Int J STD AIDS 2000;11:451-5.
42. Kwan T, Karve MM, Emerole O. Cardiac tamponade in patients infected with HIV. A report from an inner-city hospital. Chest 1993;104:1059-62.
43. Lewis W. Atherosclerosis in AIDS: Potential pathogenetic roles of antiretroviral therapy and HIV. J Mol Cell Cardiol 2000;32:2115-29.
44. Lewis W. Cardiomyopathy in AIDS: A pathophysiological perspective. Prog Cardiovasc Dis 2000;43:151-70.
45. Lipshultz SE, Fox CM, Perez-Atayde AR, Sanders SP, Colan SD, McIntosh K, Winter HS. Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immunodeficiency syndrome. Am J Cardiol 1990;66:246-51.
46. Lopez JA, Ross RS, Fishbein M, Siegel RJ. Nonbacterial thrombotic endocarditis: A review. Am Heart J 1987;113:773-84.
47. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension. Chest 2000;118:1133-41.
48. Mette SA, Palevsky HI, Pietra GG, Williams TM, Bruder T, Prestipino AJ, Patrick AM, Wirth JA. Primary pulmonary hypertension in association with human immunodeficiency virus infection: A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis 1992;145:1196-200.
49. Morello S, Mahbood R, Yakoushina T, Khan S, Hague K. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades. Arch Pathol Lab Med 2002;126:182-90.
50. Nahass RG, Weinstein MP, Bartels J, Gocke DJ. Infective endocarditis in intravenous drug users. A comparison of human immunodeficiency virus type 1-negative and -positive patients. J Infect Dis 1990;162:967-70.
51. Nathan PE, Arsura EL, Zappi M. Pericarditis with tamponade due to cytomegalovirus and the acquired immunodeficiency syndrome. Chest 1991;99:765-6.
52. Neumann T, Canbay A, Barkhausen M, Bartel T. Paracardial lipodystrophy versus pericardial effusion in HIV positive patients. Heart 2002;87:e4.
53. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, DiLoreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41.
54. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
55. Patel RC, Frishman WH. Cardiac involvement in HIV infection. Med Clin North Am 1996;80:1493-512.
56. Paton P, Tabib A, Loire R, Tete R. Coronary artery lesions and human immunodeficiency virus infection. Res Virol 1993;144:225-31.
57. Penzak SR, Chuck SK. Hypelipidemia associated with HIV protease inhibitor use: Pathophysiology, prevalence, risk factors and treatment. Scand J Infect Dis 2000;32:111-23.
58. Periard D, Telenti A, Sudre P, Cheseaux JJ, Halfon P, Reymond MJ, Marcovina SM, Glauser MP, Nicod P, Darioli R, Mooser V. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. Circulation 1999;100:700-5.
59. Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN. Cardiac manifestations and acquired immunodeficiency syndrome. Arch Intern Med 2000;160:602-8.
60. Silva-Cardoso J, Moura B, Martins L, Mota-Miranda A, Rocha-Goncalves F, Lecour H. Pericardial involvement in human immunodeficiency virus infection. Chest 1999;115:418-22.
61. Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, Sosman JM. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001;104:257-62.
62. Stotka JL, Good CB, Downer WR, Kapoor WN. Pericardial effusion and tamponade due to Kaposi's sarcoma in acquired immunodeficiency syndrome. Chest 1989;95:1359-61.
63. Sturm A, Noppeney R, Reimer J, Ross B, Baumgart D, Sundermann T, Sadony V, Gerken G. AIDS and non-Hodgkin's lymphoma: Initial cardiac manifestations of highly malignant B-cell lymphoma 18 years after HIV infection. Dtsch Med Wochenschr 2001;126:364-6.
64. Toma E, Poisson M, Claessens MR, Vega C, Morisset R. Herpes simplex type 2 pericarditis and bilateral facial palsy in patients with AIDS. J Infect Dis 1989; 160:553-4.
65. Wu TC, Pizzorno MC, Hayward GS, Willoughby S, Neumann DA, Rose NR, Ansari AA, Beschorner WE, Baughman KL, Herskowitz A. In situ detection of human cytomegalovirus immediate-early gene transcript within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS 1992;6:777-85
66. Ziegler JL, Bragg K, Abrams D, Beckstead J, Cogan M, Volberding P, Baer D, Wilkinson L, Rosenbaum E, Grant K. High-grade non-Hodgkin's lymphoma in patients with AIDS. Ann N Y Acad Sci 1984;437:412-9.